Physician profile
Thomas Knutson
NPI 1003109745
$882.50
in general payments reported to CMS, 2019-2025
16 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.31 · 2021: $227 · 2022: $113 · 2023: $271 · 2024: $77.19 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $288.51 | 2021-2025 | Invega Sustenna, Spravato, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $105.27 | 2022-2023 | Austedo |
| E.R. Squibb & Sons, L.L.C. | $102.96 | 2024-2025 | Cobenfy |
| Abbvie INC. | $91.05 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $57.85 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $56.43 | 2021-2024 | Rexulti |
| Neurocrine Biosciences, INC. | $41.06 | 2021 | |
| Neuronetics, INC. | $20.32 | 2022 | |
| Lundbeck LLC | $19.35 | 2022 | |
| Vanda Pharmaceuticals INC. | $18.27 | 2025 | Fanapt |
| Acadia Pharmaceuticals INC | $17.04 | 2025 | Nuplazid |
| Supernus Pharmaceuticals, INC. | $16.52 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.82 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.47 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.31 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Knutson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.